Close Menu

NEW YORK (GenomeWeb) — Through a non-targeted metabolomics study, Swedish researchers and their colleagues uncovered four novel biomarkers for coronary heart disease.

As they reported in PLOS Genetics today, researchers led by Uppsala University's Erik Ingelsson studied the metabolomes of more than 3,600 individuals to find four metabolites associated with disease risk: monoglyceride, sphingomyelin, and two types of lysophosphatidylcholine.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.

Jul
16
Sponsored by
NanoString

Join this webinar to learn how spatial resolution of gene expression in tumor tissue reveals new insights in biomarker discovery and therapeutic response.